Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Tesla Inc

Start price
Target price
Perf. (%)
€166.97
12.12.20
€183.33
12.12.21
80.18%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 80%
sell
NIO Inc. ADR

Start price
Target price
Perf. (%)
€34.20
12.12.20
-
12.12.21
1.75%
15.12.20

Innovative
EBIT growth >5% per year expected
Top 10 in its market
Known brand
Traumtanz 
12.12.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Mercadolibre Inc

Start price
Target price
Perf. (%)
€1,335.8
12.12.20
-
12.12.21
6.06%
09.01.21

Could be worthwhile Investment >10% per year
Some uniques
Medium risks for its business
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Harmony Gold Mining

Start price
Target price
Perf. (%)
€3.42
12.12.20
€8.50
12.12.21
2.92%
22.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
synergy1 
12.12.20 50%
buy
Borgwarner Inc.

Start price
Target price
Perf. (%)
€30.40
12.12.20
-
12.12.21
21.71%
14.09.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Commando 
12.12.20 50%
buy
Palantir Technologies Inc.

Start price
Target price
Perf. (%)
€23.00
12.12.20
-
12.12.21
-6.09%
11.03.21

Could be worthwhile Investment >10% per year
Savour 
12.12.20 50%
buy
Formycon AG

Start price
Target price
Perf. (%)
€65.20
12.12.20
-
12.12.21
-7.06%
11.03.21

Could be worthwhile Investment >10% per year
Savour 
12.12.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
-
12.12.21
17.84%
16.02.21

Higher risks for its business
Increased challenges to pay loans and raise capital
SpringheelJack 
12.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
FXX 
12.12.20 50%
buy
Deutsche Lufthansa AG

Start price
Target price
Perf. (%)
€9.35
12.12.20
-
12.12.21
18.32%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
FXX 
12.12.20 50%
buy
Home Depot Inc.

Start price
Target price
Perf. (%)
€218.45
12.12.20
-
12.12.21
12.86%
24.03.21

Fair valuation
High dividend yield expected
Valuable balance sheet
Little Investments for future growth
FXX 
12.12.20 0%
sell
Overstock.com

Start price
Target price
Perf. (%)
€45.56
12.12.20
-
12.12.21
74.51%
08.02.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
FXX 
12.12.20 50%
sell
Envveno Medical Corp.

Start price
Target price
Perf. (%)
€10.03
12.12.20
€4.00
12.12.21
-45.01%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
nvestor 
12.12.20 50%
sell
vTv Therapeutics Inc

Start price
Target price
Perf. (%)
€2.30
12.12.20
€1.00
12.12.21
-14.22%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
nvestor 
12.12.20 50%
sell
Sonoma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.90
12.12.20
€3.00
12.12.21
-8.48%
26.06.21

Risky Investment
Revenue decline > 20% expected
Decining EBIT margin than peer group
EBIT decline > 20% expected
nvestor 
12.12.20 50%
sell
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€3.78
12.12.20
€2.00
12.12.21
4.76%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
nvestor 
12.12.20 50%
sell
Rainforest Resources Inc.

Start price
Target price
Perf. (%)
€2.08
12.12.20
-
7.69%
15.12.20

Risky Investment
Business model of the past or high risk
Little known brand
Traumtanz 
12.12.20 50%
buy
Adyen NV ADR

Start price
Target price
Perf. (%)
€36.40
12.12.20
-
2.20%
15.12.20

Revenue growth >5% per year expected
Valuable balance sheet
Capable Management
Traumtanz 
12.12.20 50%
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€128.58
11.12.20
€183.95
11.12.21
13.77%
04.11.21

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
hbvv9498 
11.12.20 50%
buy
E.ON SE

Start price
Target price
Perf. (%)
€8.85
11.12.20
€10.00
1.33%
13.12.20

Could be worthwhile Investment >10% per year
phonebroker 
11.12.20 50%
buy
Fuchs Petrolub SE ST

Start price
Target price
Perf. (%)
€45.56
11.12.20
€48.00
5.22%
17.12.20

Could be worthwhile Investment >10% per year
Known brand
Good culture
phonebroker 
11.12.20 50%
buy
E.ON SE

Start price
Target price
Perf. (%)
€8.89
11.12.20
€11.00
-0.43%
11.12.20

Could be worthwhile Investment >10% per year
phonebroker 
11.12.20 50%
sell
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€392.75
11.12.20
€250.00
0.97%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
11.12.20 50%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€48.87
11.12.20
€50.00
-14.92%
17.12.20

Traumtanz 
11.12.20 50%